Codoxo
At Codoxo, formerly Fraudscope, we’re on a mission to make our healthcare system more affordable and effective.
At Codoxo, formerly Fraudscope, we’re on a mission to make our healthcare system more affordable and effective.
Codoxo, formerly known as Fraudscope, is a company focused on revolutionizing the healthcare system to be more cost-effective and efficient. Their Forensic AI Platform, powered by a patented algorithm, is designed to detect issues and suspicious activities earlier than traditional methods, ensuring that healthcare funds are allocated to genuine patient care. The company, founded in 2017, operates in the AI, Analytics, Big Data, Health Care, Insurtech, Health insurance, and Machine Learning industries, with its headquarters in the United States. Codoxo recently secured a $5.25M Series B investment on 03 February 2022, with notable investors including QED Investors, Spider Capital, Brewer Lane Ventures, Sands Capital Ventures, 111 West, and GRA Venture Fund. With a focus on transforming the healthcare system, Codoxo presents an intriguing opportunity for investors seeking to support innovative solutions in the healthcare and AI sectors. For those interested in learning more about their offerings, they can schedule a demo by contacting [email protected].
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | $5.25M | 6 |
|
03 Feb 2022 |
| Series A | $7.00M | 6 |
|
02 Jul 2020 |
| Seed Round | $475.00K | - | 21 Jun 2018 | |
| Seed Round | $1.50M | 5 |
|
15 Jun 2017 |
| Seed Round | $100.00K | 1 |
|
01 Oct 2016 |
No recent news or press coverage available for Codoxo.
We care about your data, and we'd love to use cookies make your experience better.
